10 September 2021

GreenBone Ortho Srl at Trauma Meeting

GreenBone Ortho will attend the 13th Trauma Meeting at the Palazzo Dei Congressi in Riccione  from October the 6th to the. 8th 2021. We are waiting […]
30 July 2021

GreenBone achieves aim of recruiting 15 patients into the GreenBRIC study in the treatment of iliac crest reconstruction.

GreenBone Ortho today announces that it has achieved its aim of recruiting 15 patients into the GreenBRIC study. GreenBRIC study is a prospective, open label, single-arm, […]
13 April 2021

GreenBone closes a 10mio Series B round

GreenBone Ortho SpA has completed a EURO 10 million Round B of investment fully covered by current shareholders – 3B Future Health Fund, Innogest SGR, Meta […]
26 March 2021

GreenBone announces its partnership with Clinica Mobile

GreenBone Ortho SpA announces its worldwide partnership with Clinica Mobile for the 2021 season. Clinica Mobile is the medical and physiotherapy group of the MotoGP and […]
4 February 2020

The GreenBone bone substitute achieves CE certification

With the approval of the CE mark, GreenBone officially enters the market with a completely innovative product, which provides orthopedic surgeons and traumatologists with an alternative […]
21 May 2018

GreenBone Ortho Srl at Trauma Meeting

GreenBone Ortho Srl will attend the 12th edition of the “Trauma Meeting” organized by the O.T.O.D.I. Society  at the Palazzo Dei Congressi in Riccione (RN) from […]

Caution

 

You are entering an area containing information intended for healthcare professionals. If you are a healthcare professional, click here to continue.

 

 

Continue

GreenBoneTM Bone Substitute received CE mark approval